Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 1.430-1.460 for the period, compared to the consensus EPS estimate of 1.480. The company issued revenue guidance of -.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Mizuho restated a "neutral" rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Truist Financial lowered shares of Sabra Health Care REIT from a "buy" rating to a "hold" rating and lowered their target price for the stock from $18.00 to $17.00 in a report on Friday, January 17th. JMP Securities upgraded shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $18.86.
View Our Latest Analysis on SBRA
Sabra Health Care REIT Stock Performance
Shares of SBRA stock traded down $0.50 during trading hours on Friday, hitting $15.89. 2,553,591 shares of the company were exchanged, compared to its average volume of 2,069,511. The firm has a fifty day simple moving average of $16.85 and a 200 day simple moving average of $17.62. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a 52-week low of $13.31 and a 52-week high of $20.03. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of 29.98, a P/E/G ratio of 1.99 and a beta of 1.25.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.59%. The company had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. Research analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 7.55%. Sabra Health Care REIT's payout ratio is currently 226.42%.
Sabra Health Care REIT Company Profile
(
Get Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.